136 related articles for article (PubMed ID: 12234697)
1. Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer.
Van Schil P; van der Schoot J; Poniewierski J; Pauwels M; Carp L; Germonpré P; De Backer W
Lung Cancer; 2002 Sep; 37(3):281-5. PubMed ID: 12234697
[TBL] [Abstract][Full Text] [Related]
2. Accuracy and survival of repeat mediastinoscopy after induction therapy for non-small cell lung cancer in a combined series of 104 patients.
De Waele M; Serra-Mitjans M; Hendriks J; Lauwers P; Belda-Sanchis J; Van Schil P; Rami-Porta R
Eur J Cardiothorac Surg; 2008 May; 33(5):824-8. PubMed ID: 18342528
[TBL] [Abstract][Full Text] [Related]
3. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy.
De Waele M; Hendriks J; Lauwers P; Ortmanns P; Vanroelen W; Morel AM; Germonpré P; Van Schil P
Eur J Cardiothorac Surg; 2006 Feb; 29(2):240-3. PubMed ID: 16386916
[TBL] [Abstract][Full Text] [Related]
4. Remediastinoscopy in restaging of lung cancer after induction therapy.
Marra A; Hillejan L; Fechner S; Stamatis G
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):843-9. PubMed ID: 18374765
[TBL] [Abstract][Full Text] [Related]
5. Remediastinoscopy.
Van Schil P; De Waele M; Hendriks J; Lauwers P
J Thorac Oncol; 2007 Apr; 2(4):365-6. PubMed ID: 17409813
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
[TBL] [Abstract][Full Text] [Related]
7. Remediastinoscopy after induction chemotherapy in non-small cell lung cancer.
Mateu-Navarro M; Rami-Porta R; Bastus-Piulats R; Cirera-Nogueras L; González-Pont G
Ann Thorac Surg; 2000 Aug; 70(2):391-5. PubMed ID: 10969650
[TBL] [Abstract][Full Text] [Related]
8. A second mediastinoscopy: how to decide and how to do it?
Van Schil PE; De Waele M
Eur J Cardiothorac Surg; 2008 Apr; 33(4):703-6. PubMed ID: 18258447
[TBL] [Abstract][Full Text] [Related]
9. Repeat mediastinoscopy in the staging of lung cancer.
Pauwels M; Van Schil P; De Backer W; Van den Brande F; Eyskens E
Eur J Cardiothorac Surg; 1998 Sep; 14(3):271-3. PubMed ID: 9761436
[TBL] [Abstract][Full Text] [Related]
10. Invasive staging of mediastinal lymph nodes: mediastinoscopy and remediastinoscopy.
Rami-Porta R; Call S
Thorac Surg Clin; 2012 May; 22(2):177-89. PubMed ID: 22520285
[TBL] [Abstract][Full Text] [Related]
11. FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology.
Ryu JS; Choi NC; Fischman AJ; Lynch TJ; Mathisen DJ
Lung Cancer; 2002 Feb; 35(2):179-87. PubMed ID: 11804691
[TBL] [Abstract][Full Text] [Related]
12. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
[TBL] [Abstract][Full Text] [Related]
13. Decision making about operability in non-small cell lung cancer.
Van Schil P; Hendriks J; De Maeseneer M; Vandenbroeck Ch; Lauwers P
Acta Chir Belg; 2007; 107(5):495-9. PubMed ID: 18074906
[TBL] [Abstract][Full Text] [Related]
14. The restaging issue.
Van Schil P
Lung Cancer; 2003 Dec; 42 Suppl 1():S39-45. PubMed ID: 14611913
[TBL] [Abstract][Full Text] [Related]
15. Repeat mediastinoscopy in all its indications: experience with 96 patients and 101 procedures.
Call S; Rami-Porta R; Obiols C; Serra-Mitjans M; Gonzalez-Pont G; Bastús-Piulats R; Quintana S; Belda-Sanchis J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):1022-7. PubMed ID: 21112217
[TBL] [Abstract][Full Text] [Related]
16. Pre- and intra-operative mediastinal staging in non-small-cell lung cancer.
Lardinois D
Swiss Med Wkly; 2011; 141():w13168. PubMed ID: 21384283
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of remediastinoscopy: influence of adhesions, multilevel N2 involvement, or surgical technique?
Van Schil P; Stamatis G
J Clin Oncol; 2006 Nov; 24(33):5338; author reply 5339-40. PubMed ID: 17114674
[No Abstract] [Full Text] [Related]
18. Mediastinal restaging: EUS-FNA offers a new perspective.
Annema JT; Veseliç M; Versteegh MI; Willems LN; Rabe KF
Lung Cancer; 2003 Dec; 42(3):311-8. PubMed ID: 14644519
[TBL] [Abstract][Full Text] [Related]
19. The current role of invasive staging in lung cancer.
Van Schil P; Van den Brande F
Monaldi Arch Chest Dis; 1997 Jun; 52(3):237-41. PubMed ID: 9270250
[TBL] [Abstract][Full Text] [Related]
20. Endobronchial ultrasound-guided needle aspiration in non-small-cell lung cancer restaging verified by the transcervical bilateral extended mediastinal lymphadenectomy--a prospective study.
Szlubowski A; Herth FJ; Soja J; Kołodziej M; Figura J; Cmiel A; Obrochta A; Pankowski J
Eur J Cardiothorac Surg; 2010 May; 37(5):1180-4. PubMed ID: 20022759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
